Cargando…

Recent Advances in the Treatment of C. difficile Using Biotherapeutic Agents [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812040/ https://www.ncbi.nlm.nih.gov/pubmed/33469324 http://dx.doi.org/10.2147/IDR.S289562

Ejemplares similares

Recent advances in the treatment of C. difficile using biotherapeutic agents
por: Giau, Vo Van, et al.
Publicado: (2019)

Corrigendum to “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases”
por: Kumar, Manoj, et al.
Publicado: (2022)

Corrigendum to “Recent Advances in Microwave Imaging for Breast Cancer Detection”
por: Kwon, Sollip, et al.
Publicado: (2018)

Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
por: Zhong, Xiaotian, et al.
Publicado: (2021)

Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
por: Golan, Yoav, et al.
Publicado: (2021)

Corrigendum to “Detecting Clostridioides (Clostridium) difficile using canine teams: What does the nose know?” [Infect Prev Pract 1 (2019) 100005]
por: Charles, M.K., et al.
Publicado: (2020)

Corrigendum: Direct-acting antiviral agents in Hepatitis C Virus infected renal allograft recipients: Treatment and outcome experience from single center
Publicado: (2018)

Corrigendum to “New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy”
por: Guo, Qiujun, et al.
Publicado: (2018)

The Emerging Biotherapeutic Agent: Akkermansia
por: Kalia, Vipin Chandra, et al.
Publicado: (2021)

Corrigendum to: Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridioides difficile Infections
por: Yin, Jianyi, et al.
Publicado: (2020)

Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)

Corrigendum to “Advances of Techniques in Deep Regional Blocks”
por: Lin, Jui-An, et al.
Publicado: (2018)

Corrigendum to “Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms”
por: Kuang, Xinyi, et al.
Publicado: (2021)

Corrigendum to “Oral Adverse Reactions Caused by Over-the-Counter Oral Agents”
por: Boras, Vanja Vucicevic, et al.
Publicado: (2019)

Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience [Corrigendum]
Publicado: (2014)

Clostridioides difficile infection: microbe-microbe interactions and live biotherapeutics
por: Wang, Ruojun
Publicado: (2023)

The Advancing Mental Health Equality Collaborative: Using Quality Improvement to Advance Equality in Mental Health Care – CORRIGENDUM
por: de Bono, Adele, et al.
Publicado: (2023)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Publicado: (2021)

Corrigendum to “Erbium-Based Perfusion Contrast Agent for Small-Animal Microvessel Imaging”
por: Tse, Justin J., et al.
Publicado: (2018)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults [Corrigendum]
Publicado: (2019)

Corrigendum to: Advances in plant reproduction: from gametes to seeds
por: Pereira, Ana Marta, et al.
Publicado: (2020)

Corrigendum in “Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C”
por: Pavan, Maria Helena Postal, et al.
Publicado: (2013)

Daclatasvir: potential role in hepatitis C [Corrigendum]
Publicado: (2014)

Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic Development
por: Lu, Yanmei, et al.
Publicado: (2016)

Corrigendum: Table and Text Correction. Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians
por: Iqbal, Ahmed, et al.
Publicado: (2018)

Corrigendum to “Different Presentation and Outcomes in the Surgical Treatment of Advanced MRONJ in Oncological and Nononcological Patients Taking or Not Corticosteroid Therapy”
por: Garzino-Demo, Paolo, et al.
Publicado: (2021)

Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents [Corrigendum]
Publicado: (2018)

Corrigendum to “High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI”
por: Ahmed, Sheikh Sohail, et al.
Publicado: (2015)

Corrigendum: Estimation of C. elegans cell- and tissue volumes
Publicado: (2022)

On Carlsbad Treatment for Anglo-Indians: Corrigendum
Publicado: (1891)

The Trend of Labor Analgesia in the World and China: A Bibliometric Analysis of Publications in Recent 30 Years [Corrigendum]
Publicado: (2021)

Corrigendum: Geographic population structure in an outcrossing plant invasion after centuries of cultivation and recent founding events
por: Gaskin, John F, et al.
Publicado: (2018)

Corrigendum to “Herbal Mouthwash Containing Extracts of Baccharis dracunculifolia as Agent for the Control of Biofilm: Clinical Evaluation in Humans”
por: Pedrazzi, Vinícius, et al.
Publicado: (2016)

Corrigendum to: Effects of Arthrocen, an avocado/soy unsaponifiables agent, on inflammatory mediators and gene expression in human chondrocytes
Publicado: (2018)

Corrigendum to ’Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses’: Biomedical Engineering Advances 4 (2022) 100054
por: Lim, H.T., et al.
Publicado: (2023)

Corrigendum to: Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions
por: Cushing, Kelly C, et al.
Publicado: (2021)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
Publicado: (2016)

Corrigendum to “Nonintrusive Load Monitoring Based on Advanced Deep Learning and Novel Signature”
por: Kim, Jihyun, et al.
Publicado: (2018)

Corrigendum to “Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review”
por: Lu, Lei, et al.
Publicado: (2018)

The Application and Influence of Hospice Care Among Patients with Advanced Esophageal Cancer [Corrigendum]
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v8l91ab3pqghhgedg0nb1gb16t